These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6477542)

  • 21. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in continuous glucose monitoring.
    Freckmann G; Kalatz B; Pfeiffer B; Hoss U; Haug C
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S347-57. PubMed ID: 11460583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo characteristics of needle-type glucose sensor--measurements of subcutaneous glucose concentrations in human volunteers.
    Shichiri M; Yamasaki Y; Nao K; Sekiya M; Ueda N
    Horm Metab Res Suppl; 1988; 20():17-20. PubMed ID: 3248784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis.
    Pfeiffer EF; Meyerhoff C; Bischof F; Keck FS; Kerner W
    Horm Metab Res; 1993 Feb; 25(2):121-4. PubMed ID: 8458608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensor-augmented pump therapy in type 1 diabetes.
    Weinzimer SA; Tamborlane WV
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):118-22. PubMed ID: 18316945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell.
    Freyse EJ; Fischer U; Albrecht G
    Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term clinical application of wearable artificial endocrine pancreas].
    Sakakida M; Nishida K; Shimoda S; Matsuo Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():613-9. PubMed ID: 12387059
    [No Abstract]   [Full Text] [Related]  

  • 30. [Artificial pancreas: study methods and control of glycemia equilibrium in diabetic patients].
    Altomare E; Moulin JP; Vialettes B; Bourelly N; Vague P
    Boll Soc Ital Biol Sper; 1979 May; 55(10):961-6. PubMed ID: 508411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glucose sensor. Some results and applications.
    Christensen SE; Schmitz O; Hansen AP; Orskov H
    Acta Med Scand Suppl; 1983; 671():121-8. PubMed ID: 6410697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early post-prandial hyperglycemic response: from case reports of insulin-dependent diabetics evaluated with an artificial pancreas].
    Sinagra D; La Sala MS; Cangemi C; Amato MP
    Boll Soc Ital Biol Sper; 1984 May; 60(5):913-8. PubMed ID: 6466472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Artificial and bioartificial pancreas for the treatment of diabetes mellitus].
    Reach G
    Diabete Metab; 1994; 20(2 Pt 2):183-93. PubMed ID: 8001705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas.
    Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Hakui N; Abe H
    Diabetologia; 1983 Mar; 24(3):179-84. PubMed ID: 6341145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intensified insulin therapy and insulin micro-pumps during pregnancy].
    Galuppi V
    Minerva Endocrinol; 1994 Jun; 19(2):79-83. PubMed ID: 7968932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
    Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
    Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of individual insulin infusion profiles for open loop infusion systems.
    Strack T; Krause U; Schulz G; Beyer J; Beutelspacher F; Nagel J
    Horm Metab Res; 1984 Apr; 16(4):163-7. PubMed ID: 6547110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes.
    Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC
    Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.